Pfizer, Merck Q4 earnings: A breakdown of the pharma stocks
In This Article:
Earnings are painting a mixed picture within the pharmaceutical space Tuesday morning, as Merck (MRK) and Pfizer (PFE) reported their fourth quarter results.
Yahoo Finance senior health reporter Anjalee Khemlani joins Morning Brief hosts Seana Smith and Brad Smith to break down the performance of the two pharma stocks, citing Merck's weak guidance and Gardisil oversupply in China, while outlining Pfizer's earnings and revenue beats and 2025 outlook.
To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.
This post was written by Josh Lynch
Related Videos
Terms and Privacy Policy